A presentation at the recent Clinical Virology Symposium3
demonstrated that Virocult would maintain influenza type A virus in a viable condition for at least 8 days at both refrigerated and room temperatures, while also being compatible with the many molecular techniques for routine rapid identification of known strains.
Virocult® conforms to CLSI's M40-A standard4
for transport devices is approved and registered for use throughout the world, including the US and Canada.
1. WHO - Public Health Emergency of International Concern, Date: 25 Mar 2009 Statement by WHO director-general, Dr Margaret Chan [25 Apr 2009]
2. CDC Health Advisory Distributed via Health Alert Network April 25, 2009, 3:00 EST (03:00 PM EDT) CDCHAN-000281-2009-04-25-ALT-N Investigation and Interim Recommendations: Swine Influenza (H1N1)
3. Rudsdale, A.. & D. Shedden, 20th April, 2009, Investigation of the Suitability of the Virocult® Swab Transport Device for Influenza A Specimens Which Are to be Analyzed by Cell Culture or Molecular Techniques, POSTER M42 , Clinical Virology Symposium 2009, Daytona Beach
S, 2003, Quality Control of Microbiological Transport Systems: Approved Standard NCCLS Document M40-A